This page has moved. Click here to view.
Pediatric and Adolescent AIDS
Worldwide, WHO estimates 1.1 million children living with HIV
590,000 newly infected children in 2002
In US, HIV linked to rapidly growing HIV problem in women
In US, estimated 12,240 children living with HIT in early 1994
90% of cases due to perinatal transmission in 1995
Greatest number of children in Southeast, NY/NJ/DC, Puerto Rico
Epidemiology in children in the future will reflect overlap of two trends- Epidemiology of HIV in women
and the epidemiology of good prenatal health care which can prevent much of HIV infection
Impact of ACTG 076 already evident. Pediatric AIDS rates falling nationwide, but implementation is inconsistent. In the US, AIDS in children is theoretically eradicable.
Adolescents and HIV - rapidly increasing but a talk for another day...
Perinatal transmission
Overall transmission rate 14%-39%. Closer to 25-27% in developed countries. Recent understanding of timing of transmission has improved
In utero (30-50% of transmission)
Working definition: Evidence of virus by culture/l:'CR at birth (by day 7)
Peripartum (50-75% of transmission)
Working definition: negative virus culture/PCR at birth, + after day 7
Breast Feeding
Risk clearly confirmed, magnitude modest (7-22%) but inexact
Prevention
Drug therapy - AZT
ACTG 076: AZT po beginning after wk 12, IV during delivery and po for baby 6 weeks after reduced risk by
Nucleoside Reverse Transcriptase Inhibitors )(NNRTIs)
Oidanoslne (dideoxyinosine) (ddt), VIDEX
Preparations: Pediatric powder for oral solution (when reconstituted as
Lamlvudlne (3TC), EPIVIR
Preparations: Solution: l0 mg/mL; Tablets: 150 mg
Zalcitabine (ddC), HIVID
Zidovudlne (ZDV, AZT), RETROVIR
Efavirenz (EFV), SUSTIVA
Indlnavlr, CRIXIVAN
Preparations: Capsules' 200 and 400 mg
Nelfinavir, VIRACEPT
Rltonovlr, NORVIR
Saquinavir, INVIRASETM TM (hard gel capsule) and FORTOVASETM